OPK

Opko Health, Inc. is a fully-integrated healthcare company focused on delivering solutions for serious diseases across established global markets. It develops therapies such as NGENLA™, an FDA-approved human growth hormone therapy for pediatric growth hormone deficiency, and RAYALDEE®. Opko also operates BioReference Laboratories, a full-service clinical reference laboratory that provides diagnostic services. The company engages in research to advance multispecific therapies for conditions including cancers and infectious diseases, partnering with organizations like Merck and the National Institutes of Health.